Quantitative diagnosis of breast tumors by morphometric classification of microenvironmental myoepithelial cells using a machine learning approach.

Journal: Scientific reports
PMID:

Abstract

Machine learning systems have recently received increased attention for their broad applications in several fields. In this study, we show for the first time that histological types of breast tumors can be classified using subtle morphological differences of microenvironmental myoepithelial cell nuclei without any direct information about neoplastic tumor cells. We quantitatively measured 11661 nuclei on the four histological types: normal cases, usual ductal hyperplasia and low/high grade ductal carcinoma in situ (DCIS). Using a machine learning system, we succeeded in classifying the four histological types with 90.9% accuracy. Electron microscopy observations suggested that the activity of typical myoepithelial cells in DCIS was lowered. Through these observations as well as meta-analytic database analyses, we developed a paracrine cross-talk-based biological mechanism of DCIS progressing to invasive cancer. Our observations support novel approaches in clinical computational diagnostics as well as in therapy development against progression.

Authors

  • Yoichiro Yamamoto
    Department of Pathology, Shinshu University School of Medicine, Nagano, Japan.
  • Akira Saito
    Division of Life Science and Engineering, School of Science and Engineering, Tokyo Denki University (TDU), Ishizaka, Hatoyama-Machi, Hiki-Gun, Saitama, 350-0394, Japan.
  • Ayako Tateishi
    Department of Pathology, Shinshu University School of Medicine, Nagano, Japan.
  • Hisashi Shimojo
    Department of Pathology, Shinshu University School of Medicine, Nagano, Japan.
  • Hiroyuki Kanno
    Department of Pathology, Shinshu University School of Medicine, Nagano, Japan.
  • Shinichi Tsuchiya
    Diagnostic Pathology, Ritsuzankai Iida Hospital, Nagano, Japan.
  • Ken-Ichi Ito
    Division of Breast and Endocrine Surgery, Shinshu University School of Medicine, Nagano, Japan.
  • Eric Cosatto
    Department of Machine Learning, NEC Laboratories America, NJ, USA.
  • Hans Peter Graf
    Department of Machine Learning, NEC Laboratories America, NJ, USA.
  • Rodrigo R Moraleda
    Applied Tumor Immunity Clinical Cooperation Unit, National Center for Tumor Diseases, German Cancer Research Center, Heidelberg, Germany.
  • Roland Eils
    Center for Digital Health, Berlin Institute of Health, Charité - University Medicine Berlin, Berlin, Germany. roland_eils@fudan.edu.cn.
  • Niels Grabe
    Department of Medical Oncology, National Center for Tumor Diseases, University of Heidelberg, Heidelberg, Germany.